Extracellular adenosine 5′-triphosphate in pulmonary disorders
Author:
- 1 May 2021
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 187, 114319
Abstract
No abstract availableKeywords
This publication has 126 references indexed in Scilit:
- Expression of P2X7 Receptor IncreasesIn VivoTumor GrowthCancer Research, 2012
- Natural Killer T Cell–derived IL-17 Mediates Lung Ischemia–Reperfusion InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2011
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An UpdatePharmacological Reviews, 2011
- Substance P receptor blockade decreases stretch‐induced lung cytokines and lung injury in ratsThe Journal of Physiology, 2010
- Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia–reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Basal Release of ATP: An Autocrine-Paracrine Mechanism for Cell RegulationScience Signaling, 2010
- Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activationRespiratory Research, 2009
- Acute lung inflammation and ventilator-induced lung injury caused by ATP via the P2Y receptors: an experimental studyRespiratory Research, 2008
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- The first second-generation adenosine drug enters the US marketPurinergic Signalling, 2008